Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats

European Journal of Pharmacology

Volumn 498, Issue 1-3, 2004, Pages 211-217

  Büyükafşar, Kansu ^a   Arikan, Onur ^a   Ark, Mustafa ^a   Kubat, Havva ^a   Özveren, Elif ^a  

^a Turkey ^*  (Turkey)

Author keywords

Endothelin 1; Lipopolysaccharide; Mesenteric artery; Nitric oxide; Rho kinase; Y 27632

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETYLCHOLINE; ANGIOTENSIN; BACTERIUM LIPOPOLYSACCHARIDE; ENDOTHELIN 1; PHENYLEPHRINE; RHO KINASE; RHO KINASE 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION; WESTERN BLOTTING;

ACETYLCHOLINE; AMIDES; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; FEMALE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MESENTERIC ARTERIES; NITRATES; NITRITES; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SODIUM CHLORIDE; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 4444224948     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.092     Document Type: Article

References (44)

1. M. Arditi, J. Zhou, M. Torres, D.L. Durden, M. Stins, and K.S. Kim Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells J. Immunol. 155 1995 3994 4003
2. N. Begum, N. Sandu, O. ReinzIe, and J. Ragolia Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signalling pathways Mol. Endocrinol. 14 2000 1365 1376
3. G. Bkaily, S. Choufani, S. Sader, D. Jacques, P. D'Orleans-Juste, M. Nader, G. Kurban, and M. Kamal Activation of sarcolemma and nuclear membranes ET-1 receptors regulates transcellular calcium levels in heart and vascular smooth muscle cells Can. J. Physiol. Pharm. 81 2003 654 662
4. S.S. Bolz, L. Vogel, D. Sollinger, R. Derwand, C. Boer, S.M. Pitson, S. Spiegel, and U. Pohl Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase Circulation 108 2003 342 347
5. A.M. Briones, M.J. Alonso, R. Hernanz, S. Tovar, E. Vila, and M. Salaices Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries Life Sci. 71 2002 1997 2014
6. K. Büyükafşar, and A. Levent Involvement of Rho/Rho-kinase signaling in the contractile activity and acetylcholine release in the mouse gastric fundus Biochem. Biophys. Res. Commun. 303 2003 777 781
7. K. Büyükafşar, and I. Ün Effects of Rho-kinase inhibitors, Y-27632 and fasudil on the corpus cavernosum from diabetic mice Eur. J. Pharmacol. 472 2003 235 238
8. K. Büyükafşar, A. Levent, and M. Ark Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens Br. J. Pharmacol. 140 2003 743 749
9. K. Büyükafşar, O. Arikan, M. Ark, A. Seçilmiş, I. Ün, and E. Şingirik Rho-kinase expression and its contribution to the control of perfusion pressure in the isolated rat mesenteric vascular bed Eur. J. Pharmacol. 485 2004 263 268
10. R.W. Carter, M. Begaye, and N.L. Kanagy Acute and chronic NOS inhibition enhances alpha(2)-adrenoceptor-stimulated RhoA and Rho kinase in rat aorta Am. J. Physiol., Heart Circ. Physiol. 283 2002 H1361 1369
11. K. Chitaley, and R.C. Webb Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling Hypertension 39 2002 438 442
12. 2+ influx Circ. Res. 84 1999 210 219
13. E.F. Etter, M. Eto, R.L. Wardle, D.L. Brautigan, and R.A. Murphy Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation J. Biol. Chem. 276 2001 34681 34685
14. Y. Fukata, A. Mutsuki, and K. Kaibuchi Rhoâ€"Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganisation of non-muscle cells Trends Pharmacol. Sci. 22 2001 32 39
15. S. Hippenstial, S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krüll, C. v. EIchel-StreIber, M. Goebeler, S. Ludwing, and N. Suttorp Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells Blood 95 2000 3044 3051
16. M. Hori, M. Kita, S. Torihashi, S. Miyamoto, K.J. Won, K. Sato, H. Ozak, and H. Karaki Upregulation of iNOS by COX-2 in muscularis resident macrophage of rat intestine stimulated with LPS Am. J. Physiol.: Gastrointest. Liver Physiol. 280 2001 G930 938
17. 2+ (CaM) in coronary and mesenteric arteries of endotoxemic guinea-pigs Shock 11 1999 64 71
18. C. Lan, D. Das, A. Wloskowicz, and B. Vollrath Endothelin-1 modulates haemoglobin-mediated signalling in cerebrovascular smooth muscle via RhoA/Rho kinase and protein kinase C Am. J. Physiol., Heart Circ. Physiol. 286 2004 H165 173
19. M.C. Martinez, B. Muller, J.C. Stoclet, and R. Andriantsitohaina Alteration by lipopolysaccharide of the relationship between intracellular calcium levels and contraction in rat mesenteric artery Br. J. Pharmacol. 118 1996 1218 1222
20. X.F. Ming, H. Viswambharan, C. BarandIer, J. RuffIeux, K. Kaibuchi, S. Rusconi, and Z. Yang Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells Mol. Cell. Biol. 22 2002 8467 8477
21. J.A. Mitchell, K.L. Kohlhaas, R. Sorrentino, T.D. Warner, F. Murad, and J.R. Vane Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors Br. J. Pharmacol. 109 1993 265 270
22. S. Miura, D. Fukumura, I. Kurose, H. Higuchi, H. Kimura, Y. Tsuzuki, T. Shigematsu, J.Y. Han, M. Tsuchiya, and H. Ishii Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine Am. J. Physiol. 271 1996 G461 469
23. P. Ohlmann, M.C. Martinez, B. Bucher, R. Andriantsitohaina, B. Muller, F. Schneider, and J.C. Stoclet Effect of lipopolysaccharide treatment on neurogenic contraction and noradrenaline release in rat arteries Fundam. Clin. Pharmacol. 14 2000 593 600
24. J.T. Parratt Alterations in vascular reactivity in sepsis and endotoxemia J.L. Vincent Update in Intensive Care and Emergency Medicine vol. 8 1989 Springer Verlag Berlin 299 308
25. R. Perona, S. Montaner, S. Saniger, I. Sanchez-Perez, R. Bravo, and J.C. Lacal Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins Genes Dev. 11 1997 463 475
26. H.A. Piepot, A.B.J. Groeneveld, A.A. van Lambalgen, and P. Sipkema The role of inducible nitric oxide synthase in lipopolysaccharide-mediated hyporeactivity to vasoconstrictors differs among isolated rat arteries Clin. Sci. (Lond) 102 2002 297 305
27. J.F. Pittet, D.R. Morel, A. Hemsen, K. Gunning, J.S. Lacroix, P.M. Suter, and J.M. Lundberg Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis Ann. Surg. 213 1991 261 264
28. J. Pleiner, E. Heere-Ress, H. Langenberger, A.E. Sieder, M. Bayerle-Eder, F. Mittermayer, G. Fuchsjager-Mayrl, J. Bohm, B. Jansen, and M. Wolzt Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans Arterioscler. Thromb. Vasc. Biol. 22 2002 95 100
29. O.A. Sandu, L. Ragalia, and N. Begum Diabetes in Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and smooth muscle cell relaxation Diabetes 49 2000 2178 2189
30. V. Sauzeau, M. Rolli-Derkinderen, C. MarIonneau, G. Loirand, and P. Pacaud RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation J. Biol. Chem. 278 2003 9472 9480
31. J. Schlossmann, R. Feil, and F. Hofmann Signaling through NO and cGMP-dependent protein kinases Ann. Med. 35 2003 21 27
32. F. Schneider, C. Schott, J.C. Stoclet, and G. Julou-Schaeffer l-Arginine induces relaxation of small mesenteric arteries from endotoxin-treated rats Eur. J. Pharmacol. 211 1992 269 272
33. R.R. Schumann, D. Pfeil, N. Lamping, C. Kirschning, G. Scherzinger, P. Schlag, L. Karawajew, and F. Herrmann Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14 Blood 87 1996 2805 2814
34. A.P. Somlyo, and A.V. Somlyo Signal transduction and regulation in smooth muscle Nature 372 1994 231 236
35. M. Tahara, K. Morishige, K. Sawada, I. Yoshihide, R. Kawagishi, K. Tasaka, and Y. Murata RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction Endocrinology 143 2002 920 929
36. C. Thiemermann Nitric oxide and septic shock Gen. Pharmacol. 29 1997 159 166
37. M.A. Titheradge Nitric oxide in septic shock Biochim. Biophys. Acta 1411 1999 437 455
38. I. Wakabayashi, K. Hatake, and K. Sakamoto Mechanisms of ex vivo aortic hypocontractility in endotoxemic rat Eur. J. Pharmacol. 199 1991 115 118
39. E. Weitzberg, J.M. Lundberg, and A. Rudehill Elevated plasma levels of endothelin in patient with septic syndrome Circ. Shock 33 1991 222 227
40. N. Wettschureck, and S. Offermanns Rho/Rho-kinase mediated signaling in physiology and pathophysiology J. Mol. Med. 80 2002 629 638
41. A. Wibberley, Z. Chen, E. Hu, J.P. Hieble, and T.D. Westfall Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle Br. J. Pharmacol. 138 2003 757 766
42. M.A. Wilson, G.D. Steeb, and R.N. Garrison Endothelins mediate intestinal hypoperfusion during bacteraemia J. Surg. Res. 55 1993 168 175
43. X. Wu, A.V. Somlyo, and A.P. Somlyo Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate Biochem. Biophys. Res. Commun. 220 1996 658 663
44. 2+ a negative feedback control Trends Pharmacol. Sci. 24 2003 263 266